Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024)
Trinity Biotech (TRIB) posted Consolidated Net Income of -$573000.0 for Q4 2024, up 88.13% sequentially from -$4.8 million in Q3 2024, and down 19000.0% YoY from N/an in Q1 2024.
Trinity Biotech (TRIB) Consolidated Net Income (2009 - 2024) Analysis & Trends
Trinity Biotech has reported Consolidated Net Income for 16 years, with the latest figure at -$573000.0 in Q4 2024.
- Quarterly Consolidated Net Income fell 19000.0% year-over-year to -$573000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$5.4 million (up 65.38% YoY) and the FY2025 annual result came in at -$37.4 million, down 6422.86% from the prior year.
- Consolidated Net Income advanced to -$573000.0 in Q4 2024 per TRIB's latest filing, from -$4.8 million in the prior quarter.
- Over five years, Consolidated Net Income peaked at $12.4 million in Q2 2023 and troughed at -$15.0 million in Q4 2020.
- A 5-year average of $139250.0 and a median of $374000.0 in 2022 frame the typical range for Consolidated Net Income.
- The sharpest annual moves came in 2022 and 2024: Consolidated Net Income jumped 3696.55% in 2022, then sank 482800.0% in 2024.
- Over 5 years, Consolidated Net Income stood at -$15.0 million in 2020, then jumped by 99.83% to -$25000.0 in 2021, then soared by 1444.0% to $336000.0 in 2022, then tumbled by 100.89% to -$3000.0 in 2023, then slumped by 19000.0% to -$573000.0 in 2024.
- According to Business Quant data, Consolidated Net Income over the past three periods registered -$573000.0, -$4.8 million, and -$7.0 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Trinity Biotech | 6.77 Mn | 1.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -573,000.00 |
| Sep 30, 2024 | -4.83 Mn |
| Jun 30, 2024 | -7.02 Mn |
| Mar 31, 2024 | -3.18 Mn |
| Dec 31, 2023 | -3,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 12.36 Mn |
| Mar 31, 2023 | 496,000.00 |
| Dec 31, 2022 | 336,000.00 |
| Sep 30, 2022 | 1.04 Mn |
| Jun 30, 2022 | 412,000.00 |
| Mar 31, 2022 | 791,000.00 |
| Dec 31, 2021 | -25,000.00 |
| Sep 30, 2021 | -29,000.00 |
| Jun 30, 2021 | 527,000.00 |
| Mar 31, 2021 | 4.39 Mn |
| Dec 31, 2020 | -15.01 Mn |
| Sep 30, 2020 | 8.26 Mn |
| Jun 30, 2020 | 1.76 Mn |
| Mar 31, 2020 | 3.09 Mn |